Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Ambani Orgochem Ltd

AMBANIORGO
NSE
137.95
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Ambani Orgochem Ltd

AMBANIORGO
NSE
137.95
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
106Cr
Close
Close Price
137.95
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
205.90
PS
Price To Sales
0.48
Revenue
Revenue
220Cr
Rev Gr TTM
Revenue Growth TTM
41.19%
PAT Gr TTM
PAT Growth TTM
-2.61%
Peer Comparison
How does AMBANIORGO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
AMBANIORGO
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Revenue
RevenueCr
35266167586666627482111109
Growth YoY
Revenue Growth YoY%
-16.0-30.871.8156.4-3.8-0.612.8-6.112.431.549.733.5
Expenses
ExpensesCr
33245764556461587677106103
Operating Profit
Operating ProfitCr
22433354-2457
OPM
OPM%
6.88.65.94.35.83.87.17.1-3.35.24.66.0
Other Income
Other IncomeCr
000000007000
Interest Expense
Interest ExpenseCr
121122234435
Depreciation
DepreciationCr
001111111122
PBT
PBTCr
213222321033
Tax
TaxCr
00100010-3012
PAT
PATCr
101111103-210
Growth YoY
PAT Growth YoY%
-13.2-38.337.0100.0-2.412.2-12.2-86.8171.3-1,718.2-68.3110.7
NPM
NPM%
2.61.42.11.12.11.31.60.24.0-2.20.80.2
EPS
EPS
1.60.72.61.51.60.01.10.23.3-2.50.40.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
5265807387125132136193220
Growth
Revenue Growth%
24.722.1-8.618.944.26.02.841.414.2
Expenses
ExpensesCr
4961746881119124132183208
Operating Profit
Operating ProfitCr
35556685912
OPM
OPM%
6.27.06.97.06.85.16.33.44.95.3
Other Income
Other IncomeCr
0000110-210
Interest Expense
Interest ExpenseCr
2222334788
Depreciation
DepreciationCr
0111111333
PBT
PBTCr
1222333007
Tax
TaxCr
0011111-313
PAT
PATCr
12212223-11
Growth
PAT Growth%
117.0-2.3-19.923.018.2-1.754.0-128.1231.1
NPM
NPM%
1.62.72.21.92.01.61.52.2-0.40.5
EPS
EPS
2.14.63.42.73.43.11.13.5-2.10.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
445556678
Reserves
ReservesCr
0210121324263241
Current Liabilities
Current LiabilitiesCr
2633383545556792122
Non Current Liabilities
Non Current LiabilitiesCr
898111521333129
Total Liabilities
Total LiabilitiesCr
3848616278112137176208
Current Assets
Current AssetsCr
26344846567267106123
Non Current Assets
Non Current AssetsCr
121414172241706985
Total Assets
Total AssetsCr
3848616278112137176208

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3-25-4017-1311
Investing Cash Flow
Investing Cash FlowCr
-2-1-4-6-20-38-12
Financing Cash Flow
Financing Cash FlowCr
-15-210271714-3
Net Cash Flow
Net Cash FlowCr
03-117-5110
Free Cash Flow
Free Cash FlowCr
1-31-10-12-22-13-9
CFO To PAT
CFO To PAT%
188.0-91.3330.1-222.0-2.0834.7-410.6-1,266.6
CFO To EBITDA
CFO To EBITDA%
73.0-28.889.6-64.0-0.6196.6-270.1115.0

Ratios

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0034312371527388
Price To Earnings
Price To Earnings
0.00.019.422.513.735.126.423.90.0
Price To Sales
Price To Sales
0.00.00.40.40.30.60.40.50.5
Price To Book
Price To Book
0.00.02.21.91.32.31.61.91.8
EV To EBITDA
EV To EBITDA
3.43.28.19.49.216.911.026.113.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.717.217.318.418.616.717.922.124.0
OPM
OPM%
6.27.06.97.06.85.16.33.44.9
NPM
NPM%
1.62.72.21.92.01.61.52.2-0.4
ROCE
ROCE%
19.419.816.512.910.77.79.27.48.0
ROE
ROE%
19.130.011.28.29.26.56.27.7-1.8
ROA
ROA%
2.13.72.82.22.21.81.41.7-0.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Ambani Orgochem Limited (formerly **Ambani Organics Limited**) is a specialized manufacturer, processor, and exporter of water-based specialty chemicals with over **three decades** of industrial expertise. The company operates as a single business segment under **AS 17**, focusing on high-performance solutions for diverse industrial applications. By leveraging the global **"China +1"** strategy and India’s **Atmanirbhar Bharat** initiative, the company has positioned itself as a critical player in the specialty chemicals hub of India. --- ### **Diversified Product Portfolio & Industrial Applications** The company manufactures a wide range of specialty chemicals designed to enhance efficiency and performance across several high-growth sectors. The portfolio is centered on cost-effective, sustainable development. | Segment | Primary Applications & Products | | :--- | :--- | | **Textiles** | Textile Auxiliaries, Binders, Emulsions, and finishing agents. | | **Paints & Coatings** | Paint Dryers, Metal Octoates, and additives for decorative/industrial use. | | **Pharma & Personal Care** | Salicylic Acid, Salicylic Derivatives, and Organic Peroxides. | | **Building Materials** | Construction chemicals and specialized Adhesives. | | **Paper & Carpet** | Processing chemicals for pulp, paper manufacturing, and carpet backing. | | **Performance Chemicals** | Resins and additives for the **FRP (Fiber Reinforced Plastic)** industry. | --- ### **Manufacturing Infrastructure & Quality Standards** The company has scaled its production capacity from **700 tons in 1996** to **24,000 tons** as of the latest expansion phase. * **Dahej Facility (Gujarat):** Located in the Dahej Industrial Area, this "state-of-the-art" unit is the cornerstone of the company's expansion. Following a major fire in **February 2024**, the facility underwent a **10-month** re-establishment process. Trial production resumed in **February 2025**, with full commercial operations commencing on **February 15, 2025**. * **Tarapur Facility (Maharashtra):** This site houses primary manufacturing units and a dedicated **In-house R&D Centre** (Plots N-42, N-44, and N-55, MIDC Tarapur). * **Certifications:** The company maintains **ISO 9001:2015**, **ISO 14001:2015**, and **ISO 45001:2018** certifications. Its textile chemicals are further validated by **GOTS** (Global Organic Textiles Standards) and **ZDHC** (Zero Discharge of Hazardous Chemicals) compliance. --- ### **Financial Performance & Operational Turnaround** Ambani Orgochem has demonstrated a sharp recovery in **H1 FY26**, following a period of operational disruption. The company is successfully transitioning toward a higher mix of **value-added Salicylates and Peroxide derivatives**. #### **H1 FY26 Financial Highlights (Consolidated)** | Particulars (₹ Lakhs) | H1 FY26 | H1 FY25 | YoY Growth | | :--- | :--- | :--- | :--- | | **Revenue** | **10,915.18** | **8,175.46** | **33.51%** | | **EBITDA** | **791.57** | **447.79** | **76.77%** | | **EBITDA Margin** | **7.16%** | **5.46%** | **+170 bps** | | **Net Profit (PAT)** | **19.07** | **(178.48)** | **Turnaround** | #### **Revenue Mix and Historical Context** * **Export Pivot:** There has been a significant shift toward international markets. In **FY24**, **Exports** surged to **₹141.95 crore** (up from **₹38.56 crore** in FY23), while domestic sales moderated. * **FY25 Momentum:** The company achieved a **42% growth in turnover** for the full year FY25. **EBITDA** increased by **133%** to **₹9.25 crore**, though high finance costs limited the **PBT to ₹35.93 lakhs**. * **Tarapur Resilience:** The Tarapur units achieved a turnover of **₹100.92 crore** in **H2 FY25**, a **51% growth** over the previous year. --- ### **Strategic Growth & Capital Allocation** The management, led by **Mr. Rakesh H. Shah** (MD) and **Mrs. Apooni R. Shah** (WTD), is executing a strategy focused on capacity utilization and financial deleveraging. * **Product Value Chain:** Moving beyond basic chemicals into complex **Salicylates** and **Peroxide derivative** variants to capture higher margins. * **R&D Investment:** Strengthening facilities to develop customer-specific solutions for the **100 Smart Cities** initiative and the broader construction sector. * **Capital Raising:** * **Convertible Warrants (Dec 2024):** Approved up to **1,260,000** warrants at **₹90** each (Premium of **₹80**), raising approximately **₹11.34 Crores**. * **Equity Allotment (Nov 2024):** Allotted **600,000 Equity Shares** following warrant conversion. * **Reserve Strengthening:** In FY25, the company forfeited **₹5.80 crore** (25% upfront money) from **2,900,000 warrants** due to non-payment of the balance by subscribers, transferring the amount to **General Reserves**. * **Efficiency Targets:** Active focus on reducing **finance costs**, rationalizing administrative expenditure, and improving the **working capital cycle**. --- ### **Risk Management & Recovery Status** The company has navigated significant headwinds, most notably the **February 2024 Dahej fire**. #### **Insurance Recovery (Dahej Incident)** | Claim Type | Amount / Status | | :--- | :--- | | **Material Damage (PPE & Inventory)** | **₹20.49 Crore** received in **March 2025**. | | **Loss of Profit** | Claim is **under process** as of **October 2025**. | #### **Key Risk Factors** * **Competitive Landscape:** The market is highly fragmented. Larger competitors may have superior **financial and R&D resources**, while the unorganized sector and **cheap imports** pressure pricing. * **Macroeconomic Sensitivity:** Slower GDP growth or high interest rates could impact the **home improvement** and **construction** sectors. * **Geopolitical Volatility:** Ongoing tensions in the Asian region create risks for **input prices**, **logistics**, and **supply chain stability**. * **Legal & Estimation Risks:** Auditors note inherent uncertainties in estimating **Loss of Profit** claims. While management views pending litigation receivables as **"good and recoverable,"** these remain under monitor. --- ### **Corporate Structure** Ambani Orgochem Limited operates with two key subsidiaries: 1. **Omega Woven Mills Private Limited** 2. **Om Maruti Glasswool & Wirenetting Products Private Limited** The company’s **Authorised Share Capital** stands at **₹20.00 crore**, consisting of **1.30 crore Equity Shares** and **70 lakh Preference Shares** (Face Value **₹10**).